Cellectar Biosciences Inc (CLRB.O)

+ 收藏

资产负债表(Cellectar Biosciences Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
截止日期 2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 9,564,988.0018,986,443.005,152,972.0012,682,691.0019,866,358.0017,785,322.0024,805,565.0030,634,122.00
 预付款项及其他应收款流动(元) 888,225.001,123,467.00456,679.001,163,745.00663,243.00975,936.00479,668.00760,420.00
 流动资产合计(元) 10,453,213.0020,109,910.005,609,651.0013,846,436.0020,529,601.0018,761,258.0025,285,233.0031,394,542.00
非流动资产:
 物业、厂房及设备(元) 1,090,304.00893,509.00337,434.00376,084.00418,641.00338,944.00364,838.00331,144.00
 非流动资产其他项目(元) 532,063.00547,346.00562,080.00615,936.00641,548.00219,311.00242,325.00264,500.00
 非流动资产合计(元) 1,622,367.001,440,855.00899,514.00992,020.001,060,189.00558,255.00607,163.00595,644.00
总资产(元) 12,075,580.0021,550,765.006,509,165.0014,838,456.0021,589,790.0019,319,513.0025,892,396.0031,990,186.00
流动负债:
 融资租赁负债流动(元) 58,979.0056,263.0053,640.0051,106.0050,847.00148,200.00143,843.00139,594.00
 应付账款及票据(元) 9,178,645.007,814,590.006,391,673.006,904,545.005,478,443.006,367,035.005,462,267.004,511,716.00
 衍生工具负债流动(元) 3,700,000.008,600,000.00------
 流动负债合计(元) 12,937,624.0016,470,853.006,445,313.006,955,651.005,529,290.006,515,235.005,606,110.004,651,310.00
非流动负债:
 融资租赁负债非流动(元) 494,003.00512,750.00530,856.00548,344.00552,981.0053,769.00--
 非流动负债其他项目(元) ------92,214.00129,714.00
 非流动负债合计(元) 494,003.00512,750.00530,856.00548,344.00552,981.0053,769.0092,214.00129,714.00
总负债(元) 13,431,627.0016,983,603.006,976,169.007,503,995.006,082,271.006,569,004.005,698,324.004,781,024.00
股东权益:
 普通股(元) 207.0099.0097.0097.0094.0061.0061.00611.00
 优先股(元) 1,382,023.0019,302,023.001,382,023.001,382,023.001,382,023.001,382,023.001,382,023.001,382,023.00
 股本溢价(元) 210,066,630.00195,298,922.00194,452,408.00194,032,651.00193,624,445.00183,652,376.00183,284,617.00182,864,114.00
 留存收益(元) -217,482,539.00-210,033,882.00-196,301,532.00-188,080,310.00-179,499,043.00-172,283,951.00-164,472,629.00-157,037,586.00
 归属于母公司股东权益其他项目(元) 4,677,632.00-------
 归属于母公司股东权益(元) -1,356,047.004,567,162.00-467,004.007,334,461.0015,507,519.0012,750,509.0020,194,072.0027,209,162.00
 股东权益合计(元) -1,356,047.004,567,162.00-467,004.007,334,461.0015,507,519.0012,750,509.0020,194,072.0027,209,162.00
负债及股东权益合计(元) 12,075,580.0021,550,765.006,509,165.0014,838,456.0021,589,790.0019,319,513.0025,892,396.0031,990,186.00
公告日期 2024-03-272023-11-132023-08-142023-05-042023-03-092022-11-032022-08-052022-05-10
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院